drugset / Trial / NCT00548301
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)
RandomizedParallel-groupDouble-blind
Summary
The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | — | — |